S.C. Johnson & Son, Inc. has patented a solid deodorizing composition. It consists, by weight, of 0.5-2.5% of a malodor counteractant selected from amyl cinnamaldehyde, benzophenone, benzyl benzoate, benzyl isoeugenol, benzyl phenyl acetate, benzyl salicylate, butyl cinnamate, cinnamyl butyrate, cinnamyl isovalerate, cinnamyl propionate, decyl acetate, ethyl myristate, isobutyl cinnamate, isoamyl salicylate, phenethyl benzoate, phenethyl phenyl acetate, triethyl citrate, tripropylene glycol n-butyl ether and combinations thereof; approximately 95% of at least one of an alkali metal inorganic salt and an alkaline-earth metal inorganic salt; 0.5-5% by weight aluminosilicate; and an odor masking agent.
Hair Treatment Lotion
Patent No. US 7,404,947 B2
Le Piane Di Lama, Mocogno, Italy, has been awarded a U.S. patent for a hair treatment lotion. It consists of green tea, gentian and geranium mixed with at least one solution medium that is an aqueous base or a physiological solution.
In-Grown Hair Prevention
Patent No. US 7,404,949 B2
Unilever has been awarded a method of overcoming in-grown hair. It is comprised of a cosmetic composition that includes, by weight, 0.1-30% malonic acid or a salt thereof and 1-99.9% of a cosmetically acceptable carrier. The composition is applied to an area of skin having in-grown hair prior to, concurrently with or after shaving.
P&G Patents Antiperspirant Compositions
Patent No. US 7,404,946 B2
P&G has been awarded a patent covering antiperspirant methods and compositions. This anhydrous, antiperspirant composition is comprised of a skin-adhering system comprising, a skin-adhering polymer, one or more volatile solvents, antiperspirant active and a thickening agent selected from the group consisting of organic solids, silicone solids, gellants, inorganic particulates, and mixtures thereof; and an anhydrous carrier in an amount sufficient to provide antiperspirant efficacy. In addition, the skin-adhering polymer and thickening agent are different.
U.S. Patent No. 7,407,940
Helix BioMedix, Inc., a Bothell, WA maker of boactive peptides, has been awarded a patent that covers a family of hexapeptide antimicrobial agents, including HB1345, for use as broad spectrum topical anti-infectives. HB1345 will be developed initially for dermatological indications such acne, rosacea and atopic dermatitis. Subsequent clinical applications are anticipated to include prevention of hospital acquired infections, such as those caused by MRSA and other multi-resistant pathogens.
Remover for Transfer-Resistant Makeup
Patent No. US 7,404,966 B2
Procter & Gamble has patented a method for removing transfer resistant makeup. It entails applying a safe and effective amount of a makeup-removing composition that contains 0.1-30% of a non-spherical crosslinked siloxane elastomer having a particle size of from above 10-200 microns; 10-80% of a solvent suitable for topical application to the skin having a solubility parameter of less than or equal to about 9 (cal./cm3)1/2; from 0-90% water and; and an emulsifier. The composition has a a viscosity greater than 20,000 cps.
Multi-Use Fabric Care
Patent No. US 7,405,191 B2
Unilever has patented a process for making a cast matrix solid or semi-solid multiple use fabric care article for a tumble dryer. The process entails creating a mixture that contains approximately 25% of an anionic surfactant comprising soap, 10- 60% of free fatty acid, 1-50% of a nonionic material, and from about 0.5-10% polymeric structuring agent. The mixture is poured into a mold with a sheet or fiber form of 0.2-10% of a filler nonwoven structuring agent.
Patent No. US 7,407,923 B2
Reckitt Benckiser has been awarded a patent covering a packaged detergent composition. The composition is comprised of a container that at least partly disintegrates in an aqueous environment. The container has a compartment. The detergent composition has two fluid phases and a solid, having a size sufficient to be retained by a 2.5mm mesh, substantially insoluble in the first fluid phase and second fluid phase. The movement of the solid within the container is restricted and at least one compartment of the container holds a portion of the first fluid phase and the second fluid phase. The first fluid phase has a density different from the density of the second fluid phase and the solid has a density comprised between the density of the first fluid phase and the density of the second fluid phase wherein the solid floats at an interface between the first and second fluid phases. The solid is at least partly in contact with an outer wall of the container and/or a separation wall between compartments of the container.